ES2213707T3 - Estimulacion del crecimiento oseo con un derivado peptidico de la trombina. - Google Patents

Estimulacion del crecimiento oseo con un derivado peptidico de la trombina.

Info

Publication number
ES2213707T3
ES2213707T3 ES01954752T ES01954752T ES2213707T3 ES 2213707 T3 ES2213707 T3 ES 2213707T3 ES 01954752 T ES01954752 T ES 01954752T ES 01954752 T ES01954752 T ES 01954752T ES 2213707 T3 ES2213707 T3 ES 2213707T3
Authority
ES
Spain
Prior art keywords
stimulation
growth
oseo
thrombin
peptidic derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES01954752T
Other languages
English (en)
Spanish (es)
Inventor
Darrell H Carney
Roger S Crowther
David J Simmons
Jinping Yang
William R Redin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
University of Texas at Austin
Original Assignee
University of Texas System
University of Texas at Austin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System, University of Texas at Austin filed Critical University of Texas System
Application granted granted Critical
Publication of ES2213707T3 publication Critical patent/ES2213707T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
ES01954752T 2000-07-19 2001-07-18 Estimulacion del crecimiento oseo con un derivado peptidico de la trombina. Expired - Lifetime ES2213707T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21930000P 2000-07-19 2000-07-19

Publications (1)

Publication Number Publication Date
ES2213707T3 true ES2213707T3 (es) 2004-09-01

Family

ID=22818711

Family Applications (1)

Application Number Title Priority Date Filing Date
ES01954752T Expired - Lifetime ES2213707T3 (es) 2000-07-19 2001-07-18 Estimulacion del crecimiento oseo con un derivado peptidico de la trombina.

Country Status (13)

Country Link
US (3) US6914050B2 (https=)
EP (1) EP1301196B1 (https=)
JP (2) JP3691484B2 (https=)
CN (1) CN100350971C (https=)
AT (1) ATE254925T1 (https=)
AU (2) AU2001276977B2 (https=)
CA (1) CA2416487A1 (https=)
DE (1) DE60101339T2 (https=)
DK (1) DK1301196T3 (https=)
ES (1) ES2213707T3 (https=)
PT (1) PT1301196E (https=)
TR (1) TR200400260T4 (https=)
WO (1) WO2002005836A2 (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5895766A (en) 1995-09-20 1999-04-20 Micron Technology, Inc. Method of forming a field effect transistor
CN100359015C (zh) 1998-05-18 2008-01-02 伦敦大学专科学院 多肽激素磷酸盐沉着因子
ATE254925T1 (de) 2000-07-19 2003-12-15 Univ Texas Stimulierung des knochenwachstums mit peptidderivaten von thrombin
US6911425B2 (en) * 2000-08-16 2005-06-28 Acologix, Inc. Integrin binding motif containing peptides and methods of treating skeletal diseases
JP4638653B2 (ja) 2000-08-16 2011-02-23 アコロジックス インコーポレイテッド 骨成長促進ペプチドを含む歯科用製品
JP2005519067A (ja) * 2002-01-17 2005-06-30 ザ ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム トロンビンペプチド誘導体を用いた骨成長および軟骨形成の刺激
AU2003256343B2 (en) 2002-07-02 2006-12-21 Orthologic Corp. Thrombin peptide derivatives
DE60313982T2 (de) 2002-07-02 2008-01-17 Orthologic Corp., Tempe Dimere von thrombinpeptidderivaten
US7169405B2 (en) * 2003-08-06 2007-01-30 Warsaw Orthopedic, Inc. Methods and devices for the treatment of intervertebral discs
JP4740532B2 (ja) * 2003-09-30 2011-08-03 雪印乳業株式会社 骨形成促進及び骨吸収抑制剤
US20060286084A1 (en) * 2003-09-30 2006-12-21 Yoshikazu Morita Agent for promoting osteogenesis and/or inhibiting bone resorption
US7399826B1 (en) 2003-10-02 2008-07-15 Ali Sadat M Peptide for promoting healing of fractures
CN1913917B (zh) 2003-12-31 2012-02-01 正统逻辑公司 凝血酶肽衍生物的药物组合物
WO2007011610A2 (en) 2005-07-18 2007-01-25 Acologix, Inc. Protein formulation for promoting hard tissue formation
US7879027B2 (en) * 2006-04-24 2011-02-01 Warsaw Orthopedic, Inc. Controlled release devices for fusion of osteal structures
US8642060B2 (en) * 2006-04-24 2014-02-04 Warsaw Orthopedic, Inc. Controlled release systems and methods for osteal growth
US7771414B2 (en) * 2006-04-24 2010-08-10 Warsaw Orthopedic, Inc. Controlled release devices for therapeutic treatments of spinal discs
US8642059B2 (en) * 2006-04-24 2014-02-04 Warsaw Orthopedic, Inc. Controlled release systems and methods for intervertebral discs
WO2008091632A2 (en) 2007-01-22 2008-07-31 Acologix, Inc. A peptide composition and a method of promoting cartilage formation
WO2008100567A2 (en) * 2007-02-15 2008-08-21 Orthologic Corp. Thrombin peptide derivatives for treating fractures in osteopenic patients
EP2280722A2 (en) * 2008-03-26 2011-02-09 Orthologic Corp. Method of treating degenerative diseases
CA2722621A1 (en) * 2008-03-26 2009-10-01 Orthologic Corp. Thrombin derived peptides for smooth muscle relaxation
US20110105400A1 (en) * 2008-03-26 2011-05-05 Orthologic Corp. Methods for treating acute myocardial infarction
WO2009120307A2 (en) * 2008-03-26 2009-10-01 Orthologic Corp. Method of treating peripheral arterial disease
US20110319340A1 (en) * 2008-09-19 2011-12-29 The Board Of Regents, The University Of Texas System Methods for treating cancer
CN102250253A (zh) * 2010-05-17 2011-11-23 中国人民解放军军事医学科学院军事兽医研究所 一种含凝血酶片段融合肽
RU2551119C1 (ru) * 2013-11-29 2015-05-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Национальный исследовательский Томский политехнический университет" Времяпролетный спектрометр ионов
US10220078B2 (en) 2014-06-11 2019-03-05 The Board Of Regents Of The University Of Texas System Methods of using thrombin derivatives to treat medulloblastoma

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4563489A (en) * 1984-02-10 1986-01-07 University Of California Biodegradable organic polymer delivery system for bone morphogenetic protein
US4637931A (en) * 1984-10-09 1987-01-20 The United States Of America As Represented By The Secretary Of The Army Polyactic-polyglycolic acid copolymer combined with decalcified freeze-dried bone for use as a bone repair material
US5352664A (en) * 1986-10-31 1994-10-04 Board Of Regents, The University Of Texas System Thrombin derived polypeptides; compositions and methods for use
JPH04279520A (ja) 1990-05-31 1992-10-05 Eisai Co Ltd 骨内部埋め込み用製剤
US5563124A (en) 1991-04-22 1996-10-08 Intermedics Orthopedics/ Denver, Inc. Osteogenic product and process
US5876452A (en) 1992-02-14 1999-03-02 Board Of Regents, University Of Texas System Biodegradable implant
TW369414B (en) 1994-09-30 1999-09-11 Yamanouchi Pharma Co Ltd Bone formation transplant
JPH1033657A (ja) 1996-07-23 1998-02-10 Dainippon Ink & Chem Inc 生体内分解性材料及びその製造方法
US6001352A (en) 1997-03-31 1999-12-14 Osteobiologics, Inc. Resurfacing cartilage defects with chondrocytes proliferated without differentiation using platelet-derived growth factor
EP0896825B1 (en) 1997-08-14 2002-07-17 Sulzer Innotec Ag Composition and device for in vivo cartilage repair comprising nanocapsules with osteoinductive and/or chondroinductive factors
ATE254925T1 (de) * 2000-07-19 2003-12-15 Univ Texas Stimulierung des knochenwachstums mit peptidderivaten von thrombin
AU7356101A (en) 2000-07-20 2002-02-05 Univ Texas Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor

Also Published As

Publication number Publication date
US7304035B2 (en) 2007-12-04
AU2001276977B2 (en) 2005-05-19
US20020182205A1 (en) 2002-12-05
TR200400260T4 (tr) 2004-03-22
AU7697701A (en) 2002-01-30
US6914050B2 (en) 2005-07-05
CA2416487A1 (en) 2002-01-24
US20020128202A1 (en) 2002-09-12
CN100350971C (zh) 2007-11-28
US20050227923A1 (en) 2005-10-13
CN1635899A (zh) 2005-07-06
JP2005053894A (ja) 2005-03-03
DE60101339T2 (de) 2004-09-09
HK1055250A1 (en) 2004-01-02
WO2002005836A3 (en) 2002-12-19
PT1301196E (pt) 2004-04-30
EP1301196A2 (en) 2003-04-16
JP3691484B2 (ja) 2005-09-07
EP1301196B1 (en) 2003-11-26
JP2004503596A (ja) 2004-02-05
WO2002005836A2 (en) 2002-01-24
DK1301196T3 (da) 2004-03-29
ATE254925T1 (de) 2003-12-15
DE60101339D1 (de) 2004-01-08
US6894027B2 (en) 2005-05-17

Similar Documents

Publication Publication Date Title
ES2213707T3 (es) Estimulacion del crecimiento oseo con un derivado peptidico de la trombina.
AR045179A1 (es) Uso de una combinacion de un inhibidor de la quinasa del receptor del factor de crecimiento epidermico y de agentes citotoxicos para el tratamiento e inhibicion del cancer
PA8468401A1 (es) Compuestos para el tratamiento de la isquemia
ES2172793T3 (es) Formas de dosificacion biconvexas de desintegracion rapida.
CL2008001920A1 (es) Composicion farmaceutica que comprende un inhibidor de la pde 2, un agonista del receptor selectivo e2 y un portador; y uso en el tratamiento de fractura y/o defecto oseo (div. sol. 3179-04).
AR020442A1 (es) Agonistas de 5ht2serotonergicos para el tratamiento de glaucoma
ATE264863T1 (de) 28-epirapaloge
PA8522701A1 (es) COMPUESTOS DE ACETAMIDAS BENCENICAS QUE SON ACTIVADORES DE LA GLUCOKINASA a-ACILO-Y a-HETEROATOMO-SUSTITUIDO
AR037109A1 (es) Uso de flibanserina
DK1023904T3 (da) Adjuvanser til anvendelse i vacciner
ES2157027T3 (es) Oxazolidinonas sustituidas y su uso como farmacos antibacterianos.
DE602004021799D1 (de) Implantierbare medizinische vorrichtung mit begrenzter expansion
ATE333896T1 (de) Vaskularisierungsinhibitoren
CR7610A (es) Uso de derivados de thio-oxindol en el tratamiento de condiciones realcionadas con la hormona
CY1107605T1 (el) Θεραπευτικη αγωγη
AR016981A2 (es) Polipeptidos sinteticos
ES2190205T3 (es) Combinacion para el tratamiento de la dependencia del alcohol que contiene un antagonista opioide y un modulador del complejo receptor de nmda.
MXPA03001945A (es) Tetrahidroindazoles sustituidos con arilo y su uso como ligandos para el receptor gaba-a.
UY28007A1 (es) Tratamiento terapeutico
ES2195025T3 (es) Proteinas de fusion de un dominio de factor tisular-dominio de kunitz como inhibidores del factor viia.
AR028772A1 (es) 5-aminoalquil-pirazol[4,3-d] pirimidinas
AR032422A1 (es) Uso de inhibidores de il-18 para el tratamiento y/o prevencion de la enfermedad cardiaca
CO5200833A1 (es) Regimenes de dosificacion para lasofoxifeno
PE20050665A1 (es) ESTROGENOS SELECTIVOS DE 8ß-VINIL-ESTRA-1,3,5(10)-TRIEN-3,17ß-DIOL Y 17ß-FLUOR-9-VINIL-ESTRA-1,3,6(10)-TRIEN-3,16ALFA-DIOL
UY27031A1 (es) Uso de agonistas selectivos del receptor de dopamina d4 para tratar disfunción sexual